The chemotherapy drug Taxotere, commonly used for breast cancer treatment, has been linked to severe eye injuries, permanent vision loss, and permanent hair loss.
Taxotere lawsuits are being consolidated in the US District Court for the Eastern District of Louisiana, with claims that the manufacturer, Sanofi-Aventis, did not adequately warn about the potential side effects.
Patients who have experienced vision damage, hair loss, or other related medical issues after using Taxotere may be eligible for financial compensation through a lawsuit.
Active Litigation
Taxotere Lawsuit Facts
TorHoerman Law is actively accepting claims for the Taxotere Lawsuit.
Most Recent Updates
150 Taxotere Lawsuits relating to vision loss and eye injuries are centralized in federal court.
Our Taxotere Lawyers are accepting new clients who have suffered vision loss, blurred vision, significant pain, and other visions issues after being prescribed Taxotere.
Contact us today for a free consultation or use the chat feature on this page to find out if you qualify for the Taxotere Lawsuit.
Key Takeaways
The chemotherapy drug Taxotere, commonly used for breast cancer treatment, has been linked to severe eye injuries, permanent vision loss, and permanent hair loss.
Taxotere lawsuits are being consolidated in the US District Court for the Eastern District of Louisiana, with claims that the manufacturer, Sanofi-Aventis, did not adequately warn about the potential side effects.
Patients who have experienced vision damage, hair loss, or other related medical issues after using Taxotere may be eligible for financial compensation through a lawsuit.
Taxotere Lawsuit Update and Overview
The popular chemotherapy drug Taxotere has been linked to severe eye injuries and permanent hair loss.
Taxotere Lawsuits are being filed by breast cancer patients and others who have taken the chemotherapy drug and subsequently developed vision problems such as:
Excessive tearing (epiphora)
Damaged and scarred tear ducts (canalicular stenosis)
Partial vision loss
Permanent vision loss
Severe eye pain
Other eye injuries
Taxotere Lawsuits have also been filed by breast cancer patients who have suffered hair loss due to Taxotere use, but our law firm is focused on seeking justice for Taxotere patients who have suffered from vision loss and other related injuries.
Taxotere Vision Damage Lawsuits are being consolidated into multidistrict litigation (MDL) in the US District Court for the Eastern District of Louisiana.
If you or a loved one used Taxotere and subsequently developed vision damage or other vision problems, you may be eligible to file a Taxotere Lawsuit and seek financial compensation.
Contact TorHoerman Law for a free consultation.
You can also use the chatbot on this page to find out if you qualify to file a Taxotere Lawsuit instantly.
Our law firm is committed to helping individuals secure compensation for what they’ve experienced.
Having to undergo cancer treatment is a battle in itself, but having to deal with additional health issues from using a chemotherapy drug can compound the difficulties patients are already dealing with.
Our Taxotere Lawyers are here to help you through this.
Reach out to us for a free consultation or use the chatbot on this page for an instant case evaluation.
Sanofi-Aventis first started facing Taxotere Lawsuits over the potentially permanent hair loss side effects of the drug.
Recently, the potential vision loss side effects of Taxotere have triggered the formation of a Taxotere Eye Injury MDL.
Taxotere Hair Loss Lawsuits and Taxotere Vision Damage Lawsuits are consolidated into different multidistrict litigations.
The Taxotere Hair Loss Lawsuits are consolidated into MDL 2740 and Taxotere Vision Damage Lawsuits are consolidated into MDL 3023.
Taxotere Lawsuits claim that Sanofi-Aventis did not adequately warn patients and warn doctors about potential vision loss or permanent hair loss side effects of the drug.
What is Taxotere?
Taxotere is an intravenous chemotherapy drug belonging to the taxanes class.
Taxotere, produced by Sanofi-Aventis, is the brand name for docetaxel.
First introduced in the late 1990s, Taxotere has been used to treat various cancers, including breast, lung, prostate, and stomach cancer.
Taxotere dosing and frequency of administration may vary depending on the specific cancer being treated and an individual patient’s health status.
Taxotere is typically administered in cycles, with each cycle lasting three weeks.
The cycles are repeated until the prescribed number of cycles is completed or until the patient’s oncologist determines that the treatment should be stopped or modified.
Taxotere Lawsuit Settlement Amounts
Taxotere Lawsuits are still ongoing.
Judge Milazzo has yet to issue a ruling, and no settlements have been awarded.
These projections are just estimated settlement amounts based on past settlements in similar dangerous drug claims.
These estimates are by no means a guarantee of financial compensation in the Taxotere Lawsuit.
Contact an experienced attorney for insight on your individual case.
If you need an attorney who advocates for your rights and will fight for the compensation you deserve, look no further.
Contact TorHoerman Law for a free consultation or use the chatbot on this page to find out if you qualify for the Taxotere eye injury lawsuit.
How Many Taxotere Lawsuits Have Been Filed? Current Status of the Taxotere MDL
The Taxotere MDL continues to grow, with over 300 pending Taxotere Lawsuits filed as of January 2025.
New Taxotere Lawsuits are currently being filed by lawyers across the country.
If you or a loved one developed vision loss or other vision issues after taking Taxotere, you may be eligible to file a Taxotere Lawsuit and secure financial compensation.
Contact TorHoerman Law for a free consultation.
You can also use the chatbot on this page to find out if you qualify for the Taxotere Lawsuit instantly.
Taxotere Eye Injury MDL Developments
The Taxotere Eye Injury MDL, centralized in the Eastern District of Louisiana, continues to move forward with active case management and pretrial proceedings.
Plaintiffs, many of whom were administered Taxotere while undergoing chemotherapy, allege that the drug’s manufacturer failed to adequately warn about permanent eye injuries, including canalicular stenosis and chronic tearing.
As with the related hair loss litigation, these cases begin with the filing of Short Form Complaints, and the court has allowed plaintiffs to submit amended short form complaints under the procedures established by various Pretrial Order No. directives.
Discovery and dispositive motions remain critical stages of the litigation.
The court has issued rulings on summary judgment, including summary judgement based on statute-of-limitations defenses, underscoring the importance of timely filing and well-documented medical histories.
The MDL also uses status conferences and meetings with a dedicated settlement committee to evaluate the prospects of resolution, though no global settlement has yet been announced.
Bellwether trials play a pivotal role in testing the strength of both sides’ evidence before broader negotiations.
The MDL has already seen a jury trial in earlier Taxotere hair loss cases and anticipates a second bellwether trial for eye injury claims to further gauge liability and damages.
These outcomes will help shape the trajectory of potential settlements and inform the strategy of attorneys representing affected patients.
The breast cancer chemotherapy drug Taxotere has been associated with a number of vision-related injuries.
Specifically, it is claimed that Taxotere may secrete into the tear ducts and cause severe damage.
The damage of the tear duct system can lead to excessive tearing and pooling of tears in the eyes.
Doctors have been known to misdiagnose patients with excessive tearing symptoms, not knowing that the lacrimal system is scarred and damaged by the drug.
Vision damage injuries related to Taxotere include, but are not limited to:
Lacrimal duct obstruction
Canalicular stenosis
Punctal stenosis
Swollen eyelids
Excessive tearing (Epiphora)
Blocked tear ducts
Cystoid macular edema (vision loss)
Eye irritation
Blurred vision
Eye floaters
Severe eye pain
Other eye injuries
What Medical Treatments Do Eye Injury Patients Need?
If you begin to suffer eye related side effects of Taxotere, seek immediate treatment from a licensed medical professional.
Permanent damage to your vision is possible with Taxotere side effects.
Patients suffering from vision problems and severe eye pain may need to undergo medical treatments.
These medical treatments may include the placement of stents into nasolacrimal system, such as silicone stents or tubes and permanent jones tubes.
The eye injuries associated with docetaxel (Taxotere) for the treatment of breast cancer have been identified in scientific research for at least two decades.
Scientific studies on lacrimal duct obstruction, excessive tearing, and other eye injuries related to Taxotere cases include:
Journal of Clinical Oncology: The incidence and severity of epiphora and canalicular stenosis appears to be higher in patients receiving weekly docetaxel
Liver damage caused by chemical exposure due to Taxotere treatment.
Hepatotoxicity can cause severe complications and even be life-threatening.
Hepatotoxicity is common in patients with:
Abnormal liver function
Elevated LFT
Fluid Retention
Taxotere’s label warns that the condition may reach severe levels for some patients.
Neutropenia
A low neutrophils (specific white blood cell) count makes patients more likely to contract bacterial infections.
If gone untreated, these bacterial infections can cause severe health conditions and even death.
Patients with neutrophil counts under 1500 cells per 3 cubic millimeters of blood volume are more susceptible to develop neutropenia and are advised against using Taxotere unless necessary.
Doctors are advised to frequently check blood counts for these patients who do use Taxotere.
Hypersensitivity Reactions
Reactions like a rash, low blood pressure, and fatal anaphylaxis.
Patients who received dexamethasone premedication are most susceptible to developing these conditions.
There are people filing Taxotere Lawsuits with the help of experienced attorneys in all 50 states.
Our lawyers are investigating the cancer drug Taxotere and helping injured victims seek compensation for what they’ve gone through.
If you or a loved one suffered vision loss or other related health problems from Taxotere, you may be eligible to file a Taxotere Lawsuit.
Contact TorHoerman Law for a free consultation.
You can also use the chatbot on this page to find out if you qualify to file a Taxotere Lawsuit instantly.
Your Taxotere lawyer will work to build a strong case to prove thatliability for your injuries falls on the manufacturer.
Your Taxotere attorney will work to gather evidence to show liability, assess damages that you incurred from your injuries, file legal documents on your behalf, and work to gain you compensationfor your injuries in the form of a settlement or verdict.
Gathering Evidence for Taxotere Lawsuits
Evidence is extremely important for Taxotere vision damage lawsuits.
Your Taxotere Lawyers will help you gather evidence relevant to your case, but you can begin collecting and retaining evidence on your own.
Evidence for Taxotere Lawsuits may include:
Medical records
Treatment records
Oncology records
Proof that you received Taxotere
Photos and videos of injuries
Any other proof of Taxotere use and subsequent medical problems
Assessing Damages in Taxotere Lawsuits
Damages refer to the total amount of losses related to receiving Taxotere and subsequently developing vision loss or eye injuries.
Your Taxotere Lawyer will help you assess and calculate your damages, using collected evidence to advocate for maximum financial compensation.
Potential damages in a Taxotere Vision Loss Lawsuit may include:
Medical bills
Future medical expenses and medical costs
Pain and suffering
Emotional distress
Lost quality of life
Lost wages and earning ability
Permanent damage to vision resulting in disability
TorHoerman Law’s team of attorneys and legal support staff are experienced in products liability litigation and have a track record of securing compensation for people harmed at no fault of their own.
We understand how difficult it can be to pursue legal action as you’re dealing with breast cancer treatment and side effects of defective drugs.
Our team is here to fight on your behalf and protect your best interests as you focus on your health.
We operate on a contingency fee basis, so our clients do not ever pay any legal fees until after they have been awarded compensation.
No compensation? No fees.
If you or a loved one developed vision loss or other vision issues after taking Taxotere, you may be eligible to file a Taxotere Lawsuit and secure financial compensation.
Contact TorHoerman Law for a free consultation.
You can also use the chatbot on this page to find out if you qualify for the Taxotere Lawsuit instantly.
Across all litigations, TorHoerman Law has secured over $4 billion in negotiated settlements and verdicts.
We aren’t afraid to take on large and influential corporations that injure innocent people.
Reach out to us for more information and speak with our team today.
Taxotere (active ingredient: docetaxel) is manufactured by Sanofi-Aventis and was first approved by the U.S. Food and Drug Administration in May 1996.
Taxotere is used to treat an array of cancers but is most commonly prescribed to treat patients with locally advanced or metastatic breast cancer, which had progressed during anthracycline-based therapy or relapsed during anthracycline-based adjuvant therapy.
The drug is also used as an adjuvant treatment in combination with doxorubicin and cyclophosphamide for individuals with operable node-positive breast cancer.
Taxotere works in stopping the spread of cancerous cells by cutting off the dividing and multiplying of cells in and around a cancerous clump.
Taxotere falls under a specific class of chemotherapy treatments called taxane drugs – made from plant alkaloids.
Of the drugs used to treat breast cancer, Taxotere is the most prescribed drug in its class (taxane) – some sources estimate that 75% of breast cancer patients will receive Taxotere as a form of treatment.
TorHoerman Law is accepting lawsuits for people who have experienced vision damage or permanent vision loss after Taxotere use.
If you or a loved one used Taxotere and subsequently developed vision problems, contact TorHoerman Law to discuss your legal options today, including the possibility of filing a Taxotere Lawsuit.
The Taxotere litigation is ongoing, and Taxotere Lawsuits are being consolidated into multidistrict litigation (MDL).
Multidistrict litigation (MDL) is a special federal legal procedure designed to speed up the process of products liability litigation and ensure consistent decisions across all vision damage lawsuits.
Currently, there is not a Taxotere class action lawsuit.
Rather, Taxotere Lawsuits are consolidated into multidistrict litigation.
Multidistrict litigation is a special federal legal procedure used to consolidate cases of similar fact into one singular district court.
Multidistrict litigation and class action lawsuits are different from each other.
In multidistrict litigation, settlements are distributed to plaintiffs according to the damages and circumstances of each individual case.
In class action lawsuits, settlement compensation would be divided evenly among plaintiffs, regardless of the individual circumstances of each person.
Law firms often use “Taxotere Class Action Lawsuit”, “Taxotere Class Action MDL”, and other terms to describe the multidistrict litigation, but these terms are incorrect.
Bellwether trials are an important step in multidistrict litigation.
As multidistrict litigation consolidates cases of similar fact into one district court, some MDL plaintiffs are selected to participate in bellwether trials.
A bellwether trial is a small consolidation of lawsuits, taken from a larger group of similar cases, to be tried first.
The bellwether trial is like a practice run to help anticipate the results of future similar cases.
Temporary hair loss is a common side effect of most chemotherapy treatments.
However, most do not cause a complete loss of hair.
Studies find that among all of the side effects associated with chemotherapy, temporary hair loss has the greatest impact on a patient’s quality of life.
Taxotere has been linked to Alopecia, permanent hair loss, in those who take the drug for chemotherapeutic treatment.
Alopecia is a permanent and irreversible hair loss disease that affects all body hair, including:
Eyebrows
Eyelashes
Facial hair
Pubic hair
Multiple studies have found that Taxotere use can result in Alopecia.
Evidence of Alopecia occurring in Taxotere patients includes:
Documents from the Sanofi-funded GEICAM 9805 study – which was presented as evidence in ongoing litigation against Sanofi, that reveal that around 9.2% of patients suffered hair loss that lasted more than a decade.
A 2006 study conducted by the Rock Mountain Cancer Centers, which found that Taxotere caused 6% of women to suffer permanent alopecia.
A 2012 study published in the Annals of Oncology. Of the 20 female participants who received Taxotere, 19 developed permanent hair loss. One participant who was being treated for reoccurring breast cancer had previously undergone chemotherapy with a different drug and had complete hair regrowth, but after using Taxotere, she suffered from permanent hair loss.
Alopecia can severely affect a person’s quality of life, affect body image, and cause depression and distress.
For women who already have to struggle with the burden of breast cancer and chemotherapy, developing Alopecia can be devastating.
For breast cancer survivors, Alopecia is more than a cosmetic effect.
The disease is a constant reminder of the struggle to fight breast cancer.
The 2012 study published in the Annals of Oncology found that women who suffered from Alopecia due to Taxotere suffered “significant impairment” to their quality of life.
Patients who were prescribed Taxotere during chemotherapy allege that the manufacturer failed to adequately warn about permanent side effects linked to the drug.
While Taxotere treatment is designed to stop the spread of cancer cells, many individuals undergoing treatment reported permanent hair loss, chronic tearing, and other long-term complications that were not fully disclosed.
Clinical studies, including research from Rocky Mountain Cancer Centers, found higher rates of permanent alopecia in Taxotere patients compared to those who received other chemotherapy drugs.
The lawsuits argue that the drug’s safety profile was misrepresented, leaving patients and physicians without the full picture of potential risks when making treatment decisions.
Beyond the physical and emotional toll, these side effects contribute to significant medical costs, additional procedures, and ongoing quality-of-life challenges.
By filing suit, affected patients seek compensation for these damages and accountability from the drug’s manufacturer.
Tor Hoerman has represented injured individuals for more than 30 years, with experience spanning individual personal injury cases and nationwide mass tort litigation. His work includes car accidents, catastrophic injuries, product liability claims, and other serious injury cases. Tor has served in court-appointed leadership roles in national litigation and tried cases involving major corporate defendants.
Legally Reviewed
TorHoerman Law’s legal content is researched and written by our editorial team and attorneys for legal accuracy, clarity, and relevance. We rely on statutes, court records, government publications, medical research, and other authoritative sources when applicable. This page provides general legal information and does not constitute legal advice.
Fact-Checked
TorHoerman Law reviews its legal content for factual accuracy, current information, and relevant legal context before publication and as material developments occur. This article is provided for general informational purposes and does not constitute legal advice. For guidance about a specific case, contact TorHoerman Law.
Additional Taxotere Lawsuit resources on our website:
150 Taxotere Lawsuits relating to vision loss and eye injuries are centralized in federal court.
Our Taxotere Lawyers are accepting new clients who have suffered vision loss, blurred vision, significant pain, and other visions issues after being prescribed Taxotere.
Contact us today for a free consultation or use the chat feature on this page to find out if you qualify for the Taxotere Lawsuit.
TorHoerman Law represents people whose lives have been disrupted by serious injuries, unsafe products, and negligence. Our attorneys handle individual personal injury cases as well as national mass tort lawsuits involving major corporations.
Founded in 2009, our legal team brings more than 100 years of combined experience handling serious injury and complex civil litigation.
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
In this case, we obtained a verdict of $495 Million for our client’s child who was diagnosed with Necrotizing Enterocolitis after consuming baby formula manufactured by Abbott Laboratories.
